Min Wang

Min Wang

Auto-generated profile, based on publicly available information

Min Wang

The First Affiliated Hospital of Dali University, Dali, China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2023 in Medicine
Verified
Journal Article
Open access
MWMin Wang
Min Wang
YGYuan Gao
Yuan Gao
HCHuaqiu Chen
Huaqiu Chen
YSYing Shen
Ying Shen
JCJianjie Cheng
Jianjie Cheng
GWGuangming Wang
Guangming Wang
Ischemic strokes (ISs) are commonly treated by intravenous thrombolysis using a recombinant tissue plasminogen activator; however, successful treatment can only occur within 3 hours after the stroke. Therefore, it is crucial to determine the causes and underlying molecular mechanisms, identify molecular biomarkers for early diagnosis, and develop precise preventive treatments for strokes. We aimed to clarify the differences in gene expression, molecular mechanisms, and drug prediction approaches between IS and myocardial infarction (MI) using comprehensive bioinformatics analysis. The pathogenesis of these diseases was explored to provide directions for future clinical research. The IS (GSE58294 and GSE16561) and MI (GSE60993 and GSE141512) datasets were downloaded from the Gene Expression Omnibus database. IS and MI transcriptome data were analyzed using bioinformatics methods, and the differentially expressed genes (DEGs) were screened. A protein–protein interaction network was constructed using the STRING database and visualized using Cytoscape, and the candidate genes with high confidence scores were identified using Degree, MCC, EPC, and DMNC in the cytoHubba plug-in. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses of the DEGs were performed using the database annotation, visualization, and integrated discovery database. Network Analyst 3.0 was used to construct transcription factor (TF) – gene and microRNA (miRNA) – gene regulatory networks of the identified candidate genes. The DrugBank 5.0 database was used to identify gene–drug interactions. After bioinformatics analysis of IS and MI microarray data, 115 and 44 DEGS were obtained in IS and MI, respectively. Moreover, 8 hub genes, 2 miRNAs, and 3 TFs for IS and 8 hub genes, 13 miRNAs, and 2 TFs for MI were screened. The molecular pathology between IS and MI presented differences in terms of GO and KEGG enrichment pathways, TFs, miRNAs, and drugs. These findings provide possible directions for the diagnosis of IS and MI in the future.

21 May 2025 in BMC Neurology
Verified
Journal Article
Open access
PDF file
YYYunhui Yang
Yunhui Yang
PWPengyu Wang
Pengyu Wang
MWMin Wang
Min Wang
GWGuangming Wang
Guangming Wang
Genetic factors play an important role in ischemic stroke (IS) onset. Activating transcription factor 3 (ATF3) is a known IS biomarker; however, the association between ATF3 polymorphisms and susceptibility to IS remains unclear. Therefore, we aimed to explore the association between ATF3 single-nucleotide polymorphisms (SNPs) and genetic susceptibility to IS in a population in Dali, Yunnan, China. We included 145 patients with IS and 127 healthy controls in this case-control study. ATF3 SNP sites (rs1105899, rs1008737, rs1195474, and rs1195472) were genotyped using SNaPshot detection. Venous serum glucose (VSG), white blood cell count, total cholesterol, triglycerides, low-density lipoprotein cholesterol, and systolic blood pressure (SBP) were IS risk factors; VSG had the highest impact on IS susceptibility, whereas SBP had the lowest. Genotype distributions of rs1105899, rs1008737, and rs1195472 polymorphisms in the control group conformed to the Hardy–Weinberg equilibrium. Association analysis between ATF3 polymorphisms and IS risk showed that rs1105899, rs1008737, and rs1195474 ATF3 polymorphisms were not significantly associated with IS risk. In the codominant and superdominant model of the rs1195472 [C/T] loci, CT genotype can reduce the risk of stroke, compared with TT and CC genotypes. Haplotype AGAC was an inhibitory factor for IS. The GTEx database showed that the rs1195472 CT genotype increased ATF3 expression and was associated with its expression in individual tissues. The rs1195472 polymorphism was associated with IS risk in our study population; no significant correlation was noted between rs1105899, rs1008737, and rs1195474 polymorphisms and IS.